Author Correction: PRMT1 promotes pancreatic cancer growth and predicts poor prognosis

Cell Oncol (Dordr). 2020 Feb;43(1):63-64. doi: 10.1007/s13402-019-00480-w.

Chao Song¹, Tianwei Chen^{2

3}, Lan He⁴, Ning Ma^{2

3}, Jian-Ang Li¹, Ye-Fei Rong¹, Yuan Fang¹, Mengmeng Liu⁵, Dong Xie^{6

7}, Wenhui Lou⁸

¹ Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
² Laboratory of Molecular Oncology, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Rd., Shanghai, 200031, China.
³ University of the Chinese Academy of Sciences, Shanghai, 200031, China.
⁴ School of Life Science and Technology, Shanghai Tech University, Shanghai, 201210, China.
⁵ Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai, 20032, China.
⁶ Laboratory of Molecular Oncology, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Rd., Shanghai, 200031, China. dxie@sibs.ac.cn.
⁷ University of the Chinese Academy of Sciences, Shanghai, 200031, China. dxie@sibs.ac.cn.
⁸ Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. lou.wenhui@zs-hospital.sh.cn.

Abstract

The authors would like to correct the following panels in Figures.